Global Lumpectomy
Global Lumpectomy

Lumpectomy Comprehensive Study by Type (Surgical Tools, Lumpectomy Systems), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2024

Lumpectomy Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 232 Pages 174 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Lumpectomy Market Overview:
Growing incidences of breast cancer will help to boost global lumpectomy market. Lumpectomy is also called as breast-conserving surgery and wide local excision. Lumpectomy is a type of surgery to remove cancer or other abnormal tissue from the breast. In this process the only portion of the breast. It helps in confirming the diagnosis and complete absence of cancer. Additionally, it is a premier treatment option for some women with early-stage breast cancer. Some of the key players profiled in the study are Sanarus (United States), ClearCut Medical (Israel), BD (United States), Vector Surgical (United States), Dune Medical Devices (Georgia), Medtronic PLC (Ireland), ZEISS (Germany), Hologic, Inc. (United States), Novian Health, Inc. (United States) and Cianna Medical (Merit Medical Systems, Inc.) (United States).

On the basis of geography, the market of Lumpectomy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Lumpectomy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in Prevalence of Breast Cancer
  • Growing In Government Initiative

Market Trend
  • Fueling Usage of Mammography for Breast Cancer Detection
  • Upsurge Awareness of Breast Cancer

Restraints
  • Stringent Government Regulations about Testing
  • High Cost of Procedure

Opportunities
  • Technological Advancement in Lumpectomy Market
  • Huge Opportunity in Emerging Economic and Highest Growth Region

Challenges
  • Unavailability of Government Programs for Young Women


Major Market Developments:

On 25th April 2019, Hologic, Inc. has announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow, and instant sample verification during breast-conserving surgeries as well as stereotactic breast biopsies.
On 12th February 2019, Dune Medical Devices recently reached the halfway point in a Post-Approval Study (PAS) for MarginProbe, with over 275 patients enrolled in the third Randomized Controlled trial on MarginProbe. and On 26th September 2018, Hologic, Inc. a global leader in women’s health has acquired Focal Therapeutics, a privately-held company. In conjunction with Hologic’s recent acquisition of Faxitron Bioptics, Focal strengthens the Company’s position in the rapidly growing market for breast-conserving surgery. The deal was established for 125 million dollars.

Target Audience:
Medical Device Manufactures, Distributors and Suppliers, Government Regulatory Bodies, Government and Private Research Organizations and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Lumpectomy market on the basis of product [Surgical Tools and Lumpectomy Systems] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Lumpectomy market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Lumpectomy industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Endomagnetics (United Kingdom) and Cook Medical (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Lumpectomy market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Surgical Tools
  • Lumpectomy Systems
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Breast Cancer
      • 3.2.2. Growing In Government Initiative
    • 3.3. Market Challenges
      • 3.3.1. Unavailability of Government Programs for Young Women
    • 3.4. Market Trends
      • 3.4.1. Fueling Usage of Mammography for Breast Cancer Detection
      • 3.4.2. Upsurge Awareness of Breast Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Lumpectomy, by Type, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Lumpectomy (Value)
      • 5.2.1. Global Lumpectomy by: Type (Value)
        • 5.2.1.1. Surgical Tools
        • 5.2.1.2. Lumpectomy Systems
      • 5.2.2. Global Lumpectomy by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Centers
      • 5.2.3. Global Lumpectomy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Lumpectomy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanarus (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ClearCut Medical (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BD (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Vector Surgical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dune Medical Devices (Georgia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic PLC (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ZEISS (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hologic, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novian Health, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cianna Medical (Merit Medical Systems, Inc.) (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Lumpectomy Sale, by Type, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Lumpectomy (Value)
      • 7.2.1. Global Lumpectomy by: Type (Value)
        • 7.2.1.1. Surgical Tools
        • 7.2.1.2. Lumpectomy Systems
      • 7.2.2. Global Lumpectomy by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Centers
      • 7.2.3. Global Lumpectomy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Lumpectomy: by Type(USD Million)
  • Table 2. Lumpectomy Surgical Tools , by Region USD Million (2013-2018)
  • Table 3. Lumpectomy Lumpectomy Systems , by Region USD Million (2013-2018)
  • Table 4. Lumpectomy: by End User(USD Million)
  • Table 5. Lumpectomy Hospitals , by Region USD Million (2013-2018)
  • Table 6. Lumpectomy Clinics , by Region USD Million (2013-2018)
  • Table 7. Lumpectomy Ambulatory Surgical Centers , by Region USD Million (2013-2018)
  • Table 8. South America Lumpectomy, by Country USD Million (2013-2018)
  • Table 9. South America Lumpectomy, by Type USD Million (2013-2018)
  • Table 10. South America Lumpectomy, by End User USD Million (2013-2018)
  • Table 11. Brazil Lumpectomy, by Type USD Million (2013-2018)
  • Table 12. Brazil Lumpectomy, by End User USD Million (2013-2018)
  • Table 13. Argentina Lumpectomy, by Type USD Million (2013-2018)
  • Table 14. Argentina Lumpectomy, by End User USD Million (2013-2018)
  • Table 15. Rest of South America Lumpectomy, by Type USD Million (2013-2018)
  • Table 16. Rest of South America Lumpectomy, by End User USD Million (2013-2018)
  • Table 17. Asia Pacific Lumpectomy, by Country USD Million (2013-2018)
  • Table 18. Asia Pacific Lumpectomy, by Type USD Million (2013-2018)
  • Table 19. Asia Pacific Lumpectomy, by End User USD Million (2013-2018)
  • Table 20. China Lumpectomy, by Type USD Million (2013-2018)
  • Table 21. China Lumpectomy, by End User USD Million (2013-2018)
  • Table 22. Japan Lumpectomy, by Type USD Million (2013-2018)
  • Table 23. Japan Lumpectomy, by End User USD Million (2013-2018)
  • Table 24. India Lumpectomy, by Type USD Million (2013-2018)
  • Table 25. India Lumpectomy, by End User USD Million (2013-2018)
  • Table 26. South Korea Lumpectomy, by Type USD Million (2013-2018)
  • Table 27. South Korea Lumpectomy, by End User USD Million (2013-2018)
  • Table 28. Taiwan Lumpectomy, by Type USD Million (2013-2018)
  • Table 29. Taiwan Lumpectomy, by End User USD Million (2013-2018)
  • Table 30. Australia Lumpectomy, by Type USD Million (2013-2018)
  • Table 31. Australia Lumpectomy, by End User USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Lumpectomy, by Type USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Lumpectomy, by End User USD Million (2013-2018)
  • Table 34. Europe Lumpectomy, by Country USD Million (2013-2018)
  • Table 35. Europe Lumpectomy, by Type USD Million (2013-2018)
  • Table 36. Europe Lumpectomy, by End User USD Million (2013-2018)
  • Table 37. Germany Lumpectomy, by Type USD Million (2013-2018)
  • Table 38. Germany Lumpectomy, by End User USD Million (2013-2018)
  • Table 39. France Lumpectomy, by Type USD Million (2013-2018)
  • Table 40. France Lumpectomy, by End User USD Million (2013-2018)
  • Table 41. Italy Lumpectomy, by Type USD Million (2013-2018)
  • Table 42. Italy Lumpectomy, by End User USD Million (2013-2018)
  • Table 43. United Kingdom Lumpectomy, by Type USD Million (2013-2018)
  • Table 44. United Kingdom Lumpectomy, by End User USD Million (2013-2018)
  • Table 45. Netherlands Lumpectomy, by Type USD Million (2013-2018)
  • Table 46. Netherlands Lumpectomy, by End User USD Million (2013-2018)
  • Table 47. Rest of Europe Lumpectomy, by Type USD Million (2013-2018)
  • Table 48. Rest of Europe Lumpectomy, by End User USD Million (2013-2018)
  • Table 49. MEA Lumpectomy, by Country USD Million (2013-2018)
  • Table 50. MEA Lumpectomy, by Type USD Million (2013-2018)
  • Table 51. MEA Lumpectomy, by End User USD Million (2013-2018)
  • Table 52. Middle East Lumpectomy, by Type USD Million (2013-2018)
  • Table 53. Middle East Lumpectomy, by End User USD Million (2013-2018)
  • Table 54. Africa Lumpectomy, by Type USD Million (2013-2018)
  • Table 55. Africa Lumpectomy, by End User USD Million (2013-2018)
  • Table 56. North America Lumpectomy, by Country USD Million (2013-2018)
  • Table 57. North America Lumpectomy, by Type USD Million (2013-2018)
  • Table 58. North America Lumpectomy, by End User USD Million (2013-2018)
  • Table 59. United States Lumpectomy, by Type USD Million (2013-2018)
  • Table 60. United States Lumpectomy, by End User USD Million (2013-2018)
  • Table 61. Canada Lumpectomy, by Type USD Million (2013-2018)
  • Table 62. Canada Lumpectomy, by End User USD Million (2013-2018)
  • Table 63. Mexico Lumpectomy, by Type USD Million (2013-2018)
  • Table 64. Mexico Lumpectomy, by End User USD Million (2013-2018)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Lumpectomy: by Type(USD Million)
  • Table 76. Lumpectomy Surgical Tools , by Region USD Million (2019-2024)
  • Table 77. Lumpectomy Lumpectomy Systems , by Region USD Million (2019-2024)
  • Table 78. Lumpectomy: by End User(USD Million)
  • Table 79. Lumpectomy Hospitals , by Region USD Million (2019-2024)
  • Table 80. Lumpectomy Clinics , by Region USD Million (2019-2024)
  • Table 81. Lumpectomy Ambulatory Surgical Centers , by Region USD Million (2019-2024)
  • Table 82. South America Lumpectomy, by Country USD Million (2019-2024)
  • Table 83. South America Lumpectomy, by Type USD Million (2019-2024)
  • Table 84. South America Lumpectomy, by End User USD Million (2019-2024)
  • Table 85. Brazil Lumpectomy, by Type USD Million (2019-2024)
  • Table 86. Brazil Lumpectomy, by End User USD Million (2019-2024)
  • Table 87. Argentina Lumpectomy, by Type USD Million (2019-2024)
  • Table 88. Argentina Lumpectomy, by End User USD Million (2019-2024)
  • Table 89. Rest of South America Lumpectomy, by Type USD Million (2019-2024)
  • Table 90. Rest of South America Lumpectomy, by End User USD Million (2019-2024)
  • Table 91. Asia Pacific Lumpectomy, by Country USD Million (2019-2024)
  • Table 92. Asia Pacific Lumpectomy, by Type USD Million (2019-2024)
  • Table 93. Asia Pacific Lumpectomy, by End User USD Million (2019-2024)
  • Table 94. China Lumpectomy, by Type USD Million (2019-2024)
  • Table 95. China Lumpectomy, by End User USD Million (2019-2024)
  • Table 96. Japan Lumpectomy, by Type USD Million (2019-2024)
  • Table 97. Japan Lumpectomy, by End User USD Million (2019-2024)
  • Table 98. India Lumpectomy, by Type USD Million (2019-2024)
  • Table 99. India Lumpectomy, by End User USD Million (2019-2024)
  • Table 100. South Korea Lumpectomy, by Type USD Million (2019-2024)
  • Table 101. South Korea Lumpectomy, by End User USD Million (2019-2024)
  • Table 102. Taiwan Lumpectomy, by Type USD Million (2019-2024)
  • Table 103. Taiwan Lumpectomy, by End User USD Million (2019-2024)
  • Table 104. Australia Lumpectomy, by Type USD Million (2019-2024)
  • Table 105. Australia Lumpectomy, by End User USD Million (2019-2024)
  • Table 106. Rest of Asia-Pacific Lumpectomy, by Type USD Million (2019-2024)
  • Table 107. Rest of Asia-Pacific Lumpectomy, by End User USD Million (2019-2024)
  • Table 108. Europe Lumpectomy, by Country USD Million (2019-2024)
  • Table 109. Europe Lumpectomy, by Type USD Million (2019-2024)
  • Table 110. Europe Lumpectomy, by End User USD Million (2019-2024)
  • Table 111. Germany Lumpectomy, by Type USD Million (2019-2024)
  • Table 112. Germany Lumpectomy, by End User USD Million (2019-2024)
  • Table 113. France Lumpectomy, by Type USD Million (2019-2024)
  • Table 114. France Lumpectomy, by End User USD Million (2019-2024)
  • Table 115. Italy Lumpectomy, by Type USD Million (2019-2024)
  • Table 116. Italy Lumpectomy, by End User USD Million (2019-2024)
  • Table 117. United Kingdom Lumpectomy, by Type USD Million (2019-2024)
  • Table 118. United Kingdom Lumpectomy, by End User USD Million (2019-2024)
  • Table 119. Netherlands Lumpectomy, by Type USD Million (2019-2024)
  • Table 120. Netherlands Lumpectomy, by End User USD Million (2019-2024)
  • Table 121. Rest of Europe Lumpectomy, by Type USD Million (2019-2024)
  • Table 122. Rest of Europe Lumpectomy, by End User USD Million (2019-2024)
  • Table 123. MEA Lumpectomy, by Country USD Million (2019-2024)
  • Table 124. MEA Lumpectomy, by Type USD Million (2019-2024)
  • Table 125. MEA Lumpectomy, by End User USD Million (2019-2024)
  • Table 126. Middle East Lumpectomy, by Type USD Million (2019-2024)
  • Table 127. Middle East Lumpectomy, by End User USD Million (2019-2024)
  • Table 128. Africa Lumpectomy, by Type USD Million (2019-2024)
  • Table 129. Africa Lumpectomy, by End User USD Million (2019-2024)
  • Table 130. North America Lumpectomy, by Country USD Million (2019-2024)
  • Table 131. North America Lumpectomy, by Type USD Million (2019-2024)
  • Table 132. North America Lumpectomy, by End User USD Million (2019-2024)
  • Table 133. United States Lumpectomy, by Type USD Million (2019-2024)
  • Table 134. United States Lumpectomy, by End User USD Million (2019-2024)
  • Table 135. Canada Lumpectomy, by Type USD Million (2019-2024)
  • Table 136. Canada Lumpectomy, by End User USD Million (2019-2024)
  • Table 137. Mexico Lumpectomy, by Type USD Million (2019-2024)
  • Table 138. Mexico Lumpectomy, by End User USD Million (2019-2024)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Lumpectomy: by Type USD Million (2013-2018)
  • Figure 5. Global Lumpectomy: by End User USD Million (2013-2018)
  • Figure 6. South America Lumpectomy Share (%), by Country
  • Figure 7. Asia Pacific Lumpectomy Share (%), by Country
  • Figure 8. Europe Lumpectomy Share (%), by Country
  • Figure 9. MEA Lumpectomy Share (%), by Country
  • Figure 10. North America Lumpectomy Share (%), by Country
  • Figure 11. Global Lumpectomy share by Players 2018 (%)
  • Figure 12. Global Lumpectomy share by Players (Top 3) 2018(%)
  • Figure 13. Global Lumpectomy share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sanarus (United States) Revenue, Net Income and Gross profit
  • Figure 16. Sanarus (United States) Revenue: by Geography 2018
  • Figure 17. ClearCut Medical (Israel) Revenue, Net Income and Gross profit
  • Figure 18. ClearCut Medical (Israel) Revenue: by Geography 2018
  • Figure 19. BD (United States) Revenue, Net Income and Gross profit
  • Figure 20. BD (United States) Revenue: by Geography 2018
  • Figure 21. Vector Surgical (United States) Revenue, Net Income and Gross profit
  • Figure 22. Vector Surgical (United States) Revenue: by Geography 2018
  • Figure 23. Dune Medical Devices (Georgia) Revenue, Net Income and Gross profit
  • Figure 24. Dune Medical Devices (Georgia) Revenue: by Geography 2018
  • Figure 25. Medtronic PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Medtronic PLC (Ireland) Revenue: by Geography 2018
  • Figure 27. ZEISS (Germany) Revenue, Net Income and Gross profit
  • Figure 28. ZEISS (Germany) Revenue: by Geography 2018
  • Figure 29. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic, Inc. (United States) Revenue: by Geography 2018
  • Figure 31. Novian Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Novian Health, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Cianna Medical (Merit Medical Systems, Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cianna Medical (Merit Medical Systems, Inc.) (United States) Revenue: by Geography 2018
  • Figure 35. Global Lumpectomy: by Type USD Million (2019-2024)
  • Figure 36. Global Lumpectomy: by End User USD Million (2019-2024)
  • Figure 37. South America Lumpectomy Share (%), by Country
  • Figure 38. Asia Pacific Lumpectomy Share (%), by Country
  • Figure 39. Europe Lumpectomy Share (%), by Country
  • Figure 40. MEA Lumpectomy Share (%), by Country
  • Figure 41. North America Lumpectomy Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Sanarus (United States)
  • ClearCut Medical (Israel)
  • BD (United States)
  • Vector Surgical (United States)
  • Dune Medical Devices (Georgia)
  • Medtronic PLC (Ireland)
  • ZEISS (Germany)
  • Hologic, Inc. (United States)
  • Novian Health, Inc. (United States)
  • Cianna Medical (Merit Medical Systems, Inc.) (United States)
Additional players considered in the study are as follows:
Endomagnetics (United Kingdom) , Cook Medical (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation